•
Sep 30, 2023

Soleno Therapeutics Q3 2023 Earnings Report

Total Revenue
$0
EPS
-$0.95
Previous year: -$0.76
+25.0%
Gross Profit
-$557K
Cash and Equivalents
$52.4M
Previous year: $19.8M
+165.5%
Free Cash Flow
-$6.33M
Previous year: -$4.66M
+36.0%
Total Assets
$63.5M
Previous year: $32M
+98.7%

Soleno Therapeutics

Soleno Therapeutics